No Data
No Data
Hong Kong stocks started “booming” in May! The Hang Seng Index reclaimed the 18,000 mark, and in April, Demon Stock added another 30% assist
On May 2, Hong Kong stocks ushered in the first trading day of May, and the three major stock indexes continued their major counterattack!
Changes in Hong Kong stocks | Cornerstone Pharmaceutical-B (02616) rose more than 26%, leading the innovative drug concept, ASCO catalyzes market conditions, institutions are optimistic about policy+health insurance marginal improvement
Zhitong Finance App learned that innovative drug concept stocks showed strong performance. As of press release, Cornerstone Pharmaceutical-B (02616) rose 26.14% to HK$1.11; Cansino Biotech (06185) rose 16.91% to HK$20.95; Gacos-B (01167) rose 14.2% to HK$1.93; Nuocheng Jianhua (09969) rose 12.31% to HK$5.2; Rongchang Biotech (09995) rose 10.2% to HK$30.8. According to the news, the research title of the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting was on April 25
Changes in Hong Kong stocks 丨 Biotech stocks continue to strengthen, the cornerstone pharmaceutical industry rises nearly 23%
Glonghui, May 2 | Cornerstone Pharmaceuticals rose nearly 23%, Cansino Biotech rose nearly 14%, Lepu Biotech rose more than 10%, and Pharmaceutical Kangde rose nearly 8.5%.
Hong Kong biotechnology stocks continued to strengthen. Cornerstone Pharmaceuticals rose nearly 23%, Gacos rose more than 14%, Cansino Biotech rose nearly 14%, Lepu Biotech rose more than 10%, and Pharmacom Kangde rose nearly 8.5%.
Hong Kong biotechnology stocks continued to strengthen. Cornerstone Pharmaceuticals rose nearly 23%, Gacos rose more than 14%, Cansino Biotech rose nearly 14%, Lepu Biotech rose more than 10%, and Pharmacom Kangde rose nearly 8.5%.
The Hang Seng Index rose more than 2%, the Hang Seng Technology Index rose 3.7%, Hong Kong biotech stocks rose higher, Cansino Biotech rose more than 10%, and Rongchang Biotech rose more than 6%.
The Hang Seng Index rose more than 2%, the Hang Seng Technology Index rose 3.7%, Hong Kong biotech stocks rose higher, Cansino Biotech rose more than 10%, and Rongchang Biotech rose more than 6%.
Changes in Hong Kong stocks | Cansino Biotech fell more than 5%, and its loss increased to 170 million yuan in the first quarter. It plans to sign a product transfer and technology licensing agreement with Shanghai Pharmaceutical Cansino
Cansino Biotech (06185) fell by more than 5%. As of press release, it was down 5.11% to HK$17.84, with a turnover of HK$15.417,300.
No Data